EBITDA Summary of Healius Limited

Healius Limited's latest annual EBITDA in 2024 was -298.09 Million AUD , down -415.74% from previous year.
Healius Limited's latest quarterly EBITDA in 2024 FY was N/A , down -13.76% from previous quarter.
Healius Limited reported an annual EBITDA of -57.8 Million AUD in 2023, down -50.07% from previous year.
Healius Limited reported an annual EBITDA of 734.8 Million AUD in 2022, up 48.26% from previous year.
Healius Limited reported a quarterly EBITDA of 70.3 Million AUD for 2024 Q4, down 0.0% from previous quarter.
Healius Limited reported a quarterly EBITDA of N/A for 2024 FY, down -13.76% from previous quarter.

Annual EBITDA Chart of Healius Limited (2024 - 1998)

Historical Annual EBITDA of Healius Limited (2024 - 1998)

Year	EBITDA	EBITDA Growth
2024	-298.09 Million AUD	-415.74%
2023	-57.8 Million AUD	-50.07%
2022	734.8 Million AUD	48.26%
2021	470.4 Million AUD	67.12%
2020	300.8 Million AUD	79.26%
2019	167.8 Million AUD	21.95%
2018	179.8 Million AUD	-42.52%
2017	-333.1 Million AUD	-22.07%
2016	271.1 Million AUD	-15.77%
2015	364.7 Million AUD	-3.84%
2014	399.09 Million AUD	4.36%
2013	363.43 Million AUD	3.53%
2012	351.05 Million AUD	19.71%
2011	293.04 Million AUD	-11.29%
2010	330.76 Million AUD	-11.92%
2009	374.58 Million AUD	134.94%
2008	148.82 Million AUD	41.52%
2007	114.3 Million AUD	20.77%
2006	94.45 Million AUD	25.04%
2005	74.75 Million AUD	42.98%
2004	52.28 Million AUD	21.68%
2003	42.96 Million AUD	49.0%
2002	29.3 Million AUD	48.41%
2001	19.43 Million AUD	69.77%
2000	11.44 Million AUD	9.48%
1999	10.45 Million AUD	126.66%
1998	4.61 Million AUD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	159.1 Million AUD	0.0%
2024 Q4	70.3 Million AUD	0.0%
2024 FY	- AUD	-13.76%
2023 FY	- AUD	-50.07%
2023 Q2	176.2 Million AUD	0.0%
2023 Q4	195.9 Million AUD	0.0%
2022 FY	- AUD	48.26%
2022 Q4	249.5 Million AUD	0.0%
2022 Q2	496.4 Million AUD	0.0%
2021 Q2	263 Million AUD	0.0%
2021 Q4	243.8 Million AUD	0.0%
2021 FY	- AUD	67.12%
2020 FY	- AUD	79.26%
2020 Q2	217.9 Million AUD	0.0%
2020 Q4	72.7 Million AUD	0.0%
2019 Q2	81.3 Million AUD	0.0%
2019 Q4	107.1 Million AUD	0.0%
2019 FY	- AUD	21.95%
2018 Q2	90.8 Million AUD	0.0%
2018 Q4	46.8 Million AUD	0.0%
2018 FY	- AUD	-42.52%
2017 Q2	122.2 Million AUD	0.0%
2017 FY	- AUD	-22.07%
2017 Q4	117.2 Million AUD	0.0%
2016 Q2	194.7 Million AUD	0.0%
2016 Q4	112.5 Million AUD	0.0%
2016 FY	- AUD	-15.77%
2015 Q2	196.12 Million AUD	0.0%
2015 FY	- AUD	-3.84%
2015 Q4	- AUD	0.0%
2014 FY	- AUD	4.36%
2014 Q4	187.34 Million AUD	0.0%
2014 Q2	191.92 Million AUD	0.0%
2013 Q4	179.45 Million AUD	0.0%
2013 Q2	183.98 Million AUD	0.0%
2013 FY	- AUD	3.53%
2012 Q2	87.18 Million AUD	19.52%
2012 FY	- AUD	19.71%
2012 Q4	- AUD	-100.0%
2012 Q3	87.18 Million AUD	0.0%
2012 Q1	72.94 Million AUD	0.0%
2011 Q4	- AUD	-100.0%
2011 Q3	72.94 Million AUD	0.0%
2011 Q1	82.1 Million AUD	0.0%
2011 FY	- AUD	-11.29%
2011 Q2	72.94 Million AUD	-11.16%
2010 Q1	91.37 Million AUD	0.0%
2010 FY	- AUD	-11.92%
2010 Q4	- AUD	-100.0%
2010 Q3	82.1 Million AUD	0.0%
2010 Q2	82.1 Million AUD	-10.14%
2009 Q3	91.37 Million AUD	0.0%
2009 Q4	- AUD	-100.0%
2009 FY	- AUD	134.94%
2009 Q1	36.54 Million AUD	0.0%
2009 Q2	91.37 Million AUD	149.99%
2008 FY	- AUD	41.52%
2008 Q3	36.54 Million AUD	0.0%
2008 Q4	- AUD	-100.0%
2008 Q2	36.54 Million AUD	28.59%
2008 Q1	28.42 Million AUD	0.0%
2007 FY	- AUD	20.77%
2007 Q4	- AUD	-100.0%
2007 Q3	28.42 Million AUD	0.0%
2007 Q2	28.42 Million AUD	21.73%
2007 Q1	23.34 Million AUD	0.0%
2006 Q4	- AUD	-100.0%
2006 Q1	22.11 Million AUD	0.0%
2006 Q2	23.34 Million AUD	5.57%
2006 Q3	23.34 Million AUD	0.0%
2006 FY	- AUD	25.04%
2005 Q1	17.58 Million AUD	0.0%
2005 FY	- AUD	42.98%
2005 Q3	22.11 Million AUD	0.0%
2005 Q2	22.11 Million AUD	25.8%
2005 Q4	- AUD	-100.0%
2004 FY	- AUD	21.68%
2004 Q2	17.58 Million AUD	26.58%
2004 Q4	- AUD	-100.0%
2004 Q1	13.88 Million AUD	0.0%
2004 Q3	17.58 Million AUD	0.0%
2003 Q4	- AUD	-100.0%
2003 Q3	13.88 Million AUD	0.0%
2003 Q2	13.88 Million AUD	55.91%
2003 FY	- AUD	49.0%
2003 Q1	8.9 Million AUD	0.0%
2002 Q4	- AUD	-100.0%
2002 Q2	8.9 Million AUD	13.76%
2002 FY	- AUD	48.41%
2002 Q1	7.83 Million AUD	0.0%
2002 Q3	8.9 Million AUD	0.0%
2001 Q1	4.22 Million AUD	0.0%
2001 Q3	7.83 Million AUD	0.0%
2001 FY	- AUD	69.77%
2001 Q2	7.83 Million AUD	85.52%
2001 Q4	- AUD	-100.0%
2000 Q4	- AUD	-100.0%
2000 Q1	3.23 Million AUD	0.0%
2000 Q3	4.22 Million AUD	0.0%
2000 FY	- AUD	9.48%
2000 Q2	4.22 Million AUD	30.57%
1999 Q4	- AUD	-100.0%
1999 Q1	1.72 Million AUD	0.0%
1999 Q3	3.23 Million AUD	0.0%
1999 Q2	3.23 Million AUD	87.56%
1999 FY	- AUD	126.66%
1998 FY	- AUD	0.0%
1998 Q3	1.72 Million AUD	0.0%
1998 Q4	1.72 Million AUD	0.0%
1998 Q2	1.72 Million AUD	0.0%

Peer EBITDA Comparison of Healius Limited

Name	EBITDA	EBITDA Difference
Australian Clinical Labs Limited	181.83 Million AUD	263.942%
BCAL Diagnostics Limited	-5.66 Million AUD	-5160.453%
Genetic Signatures Limited	-20.33 Million AUD	-1365.729%
Genetic Technologies Limited	-11.43 Million AUD	-2507.887%
Imagion Biosystems Limited	-13.69 Million AUD	-2076.424%
Integral Diagnostics Limited	12.33 Million AUD	2516.896%
INOVIQ Ltd	-6.63 Million AUD	-4393.935%
Microba Life Sciences Limited	-22.8 Million AUD	-1206.943%
Monash IVF Group Limited	13.02 Million AUD	2388.676%
Rhythm Biosciences Limited	-6.79 Million AUD	-4286.472%
Sonic Healthcare Limited	1.65 Billion AUD	117.965%

Global Stocks Search

Healius Limited (HLS.AX)

EBITDA Summary of Healius Limited

Annual EBITDA Chart of Healius Limited (2024 - 1998)

Historical Annual EBITDA of Healius Limited (2024 - 1998)

Peer EBITDA Comparison of Healius Limited